Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.

BACKGROUND Comprehensive mandatory use laws for prescription drug monitoring programs (PDMPs) have been implemented in a number of states to help address the opioid overdose epidemic. These laws may reduce opioid-related overdose deaths by increasing prescribers' use of PDMPs and reducing high-risk prescribing behaviors. METHODS We used state PDMP data to examine the effect of these mandates on prescriber registration, use of the PDMP, and on prescription-based measures of patient risk in three states-Kentucky, Ohio, and West Virginia-that implemented mandates between 2010 and 2015. We conducted comparative interrupted time series analyses to examine changes in outcome measures after the implementation of mandates in the mandate states compared to control states. RESULTS Mandatory use laws increased prescriber registration and utilization of the PDMP in the mandate states compared to controls. The multiple provider episode rate, rate of opioid prescribing, rate of overlapping opioid prescriptions, and rate of overlapping opioid/benzodiazepine prescriptions decreased in Kentucky and Ohio. Nevertheless, the magnitude of changes in these measures varied among mandates states. CONCLUSIONS These findings indicate that PDMP mandates have the potential to reduce risky opioid prescribing practices. Variation in the laws may explain why the effectiveness varied between states.

[1]  Randall Young,et al.  Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015 , 2017, MMWR. Morbidity and mortality weekly report.

[2]  E. Kilbourne,et al.  OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Original Research Article A History of Being Prescribed Controlled Substances and Risk of Drug Overdose Death , 2012 .

[3]  Leonard J Paulozzi,et al.  Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013. , 2015, Morbidity and mortality weekly report. Surveillance summaries.

[4]  Alexander C Wagenaar,et al.  Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program. , 2015, Drug and alcohol dependence.

[5]  Lawrence Scholl,et al.  Overdose deaths involving opioids, cocaine, and psychostimulants — United States, 2015–2016 , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  M. Buntin,et al.  Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates. , 2016, Health affairs.

[7]  S. Slavova,et al.  Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings. , 2018, Drug and alcohol dependence.

[8]  N. MacKinnon,et al.  Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing. , 2018, Drug and alcohol dependence.

[9]  Chris Delcher,et al.  Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses , 2018, Annals of Internal Medicine.

[10]  R. Barth,et al.  Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery , 2018, JAMA surgery.

[11]  Ariel Linden,et al.  Conducting Interrupted Time-series Analysis for Single- and Multiple-group Comparisons , 2015 .

[12]  Rita K Noonan,et al.  Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates. , 2016, Health affairs.

[13]  Svetla Slavova,et al.  Increases in Heroin Overdose Deaths — 28 States, 2010 to 2012 , 2014, Morbidity and Mortality Weekly Report.

[14]  S. Majumdar,et al.  How Do You Know Which Health Care Effectiveness Research You Can Trust? A Guide to Study Design for the Perplexed , 2015, Preventing chronic disease.

[15]  Ying Liu,et al.  Potential misuse and inappropriate prescription practices involving opioid analgesics. , 2013, The American journal of managed care.

[16]  Bryce Pardo,et al.  Do more robust prescription drug monitoring programs reduce prescription opioid overdose? , 2016, Addiction.

[17]  A. Gasparrini,et al.  Interrupted time series regression for the evaluation of public health interventions: a tutorial , 2016, International journal of epidemiology.

[18]  T. Buchmueller,et al.  The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare , 2016 .

[19]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[20]  Holly Hedegaard,et al.  Drug Overdose Deaths in the United States, 1999-2016. , 2017, NCHS data brief.

[21]  Fang Zhang,et al.  Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages. , 2018, Health affairs.

[22]  G. Pasternak,et al.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. , 2009, The journal of pain : official journal of the American Pain Society.

[23]  Hsien-Chang Lin,et al.  Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain. , 2018, Addictive behaviors.